BONE Stock News Bacterin Intl Hldgs (BONE) 5.03 08/02/2014 0

New Post Public Reply Private Reply Replies (0) Message Board

Aug 2, 2014 at 1:56 AM

Bacterin Intl Hldgs (BONE) 5.03 $BONE

Bacterin Announces Pricing of Public Offering of Common Stock
GlobeNewswire - Fri Aug 01, 7:41AM CDT
Bacterin International Holdings, Inc. (NYSE MKT:BONE), a leader in the development of bone graft material and coatings for medical applications, today announced the pricing of its previously announced underwritten public offering. The Company is offering 1,143,000 shares of its common stock at $5.70 per share and warrants to purchase 571,500 shares of its common stock at an exercise price of $7.12 per share to the public.

Bacterin Announces Public Offering of Common Stock
GlobeNewswire - Thu Jul 31, 3:05PM CDT
Bacterin International Holdings, Inc. (NYSE MKT:BONE), a leader in the development of bone graft material and coatings for medical applications, today announced that it intends to offer shares of its common stock and warrants to purchase common stock in an underwritten public offering pursuant to an effective shelf registration statement.

Cynosure (CYNO) in Focus: Stock Adds 17% in Session - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Jul 30, 8:25AM CDT
Cynosure (CYNO) was a big mover last session, with shares rising almost 17% on the day.

Luminex Corporation (LMNX) Jumps: Stock Adds 8.1% in Session - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Jul 30, 8:11AM CDT
Luminex Corporation (LMNX) was a big mover last session, as the company saw its shares rise slightly over 8% on the day.

IDEXX Laboratories Tops Q2 Earnings & Revenue Estimates - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Jul 29, 8:30AM CDT
IDEXX laboratories (IDXX) reported revenues of $390.1 million in the second quarter, increasing 10.6% year over year

Bacterin to Report Second Quarter 2014 Financial Results on August 12, 2014
GlobeNewswire - Tue Jul 29, 6:40AM CDT
Bacterin International Holdings, Inc. (NYSE MKT:BONE), a leader in the development of revolutionary bone graft material and coatings for medical applications, today announced that it will release its financial results for the period ended June 30, 2014, on August 12, 2014 at the close of the financial markets.

AngioDynamics (ANGO) Crumbles: Stock Falls 7.4% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Jul 25, 7:41AM CDT
AngioDynamics (ANGO) fell over 7% in the last trading session amid huge volumes, breaking its recent volatile trend as it is currently trading below the volatile price range of last one month.

Bacterin Announces Reverse Split of Common Stock
GlobeNewswire - Wed Jul 23, 6:30AM CDT
Bacterin International Holdings, Inc. (NYSE MKT:BONE), a leader in the development of revolutionary bone graft material and coatings for medical applications, today announced that a 1:10 reverse split of its common stock will be effective at the close of business on Friday, July 25, 2014 and in effect for trading purposes on Monday, July 28, 2014. The reverse stock split was approved by the company's shareholders at the 2014 Annual Shareholder's Meeting held June 11, 2014.

Bacterin International Holdings expects lower operating loss in the range of USD1.5m - USD1.4m for Q2 2014
M2 - Tue Jul 22, 8:50AM CDT
Bone graft company Bacterin International Holdings (NYSE MKT:BONE) stated on Monday that its preliminary operating loss is between USD1.5m and USD1.4m for the second quarter of 2014.

Bacterin Announces Preliminary Second Quarter 2014 Results
GlobeNewswire - Mon Jul 21, 4:54PM CDT
-- Second Quarter total revenue expected to be in the range of $8.75 million to $8.85 million, an increase of approximately 6-7% over the same period last year.

Bacterin Announces the Appointment of Robert Di Silvio as President
GlobeNewswire - Tue Jul 01, 7:13AM CDT
Bacterin International Holdings, Inc. (NYSE MKT:BONE), a leader in the development of revolutionary bone graft material and coatings for medical applications, is pleased to announce the addition of Robert (Bob) Di Silvio as President of the Company. Mr. Di Silvio brings over 30 years' experience serving in executive management positions in the medical industry, overseeing sales and marketing efforts in the management of medical sales operations.

Bacterin to Present at the 2014 Newport Coast Securities, Inc. Annual Equity & National Sales Conference
GlobeNewswire - Tue Jun 10, 1:38PM CDT
Bacterin International Holdings, Inc. (NYSE MKT:BONE), a leader in the development of revolutionary bone grafts and coatings for medical applications, today announced that its CFO, John Gandolfo, will present at the 2014 Newport Coast Securities, Inc. Annual Equity & National Sales Conference, to be held June 13, 2014 at the W New York Hotel. Bacterin's presentation will take place Friday, June 13, 2014 at 11 AM EST.

Why Bacterin International (BONE) Is Gaining Today
at The Street - Thu Mar 20, 11:48AM CDT
Bacterin International (BONE) is gaining on Thursday on the announcement of positive reactions to its OsteoSponge bone graft and after posting better-than-expected fiscal 2013 results.

Clinical Results on the Use of Bacterin's OsteoSponge(R) for Foot and Ankle Arthrodeses Procedures Published in Orthopedics Today
Business Wire - Thu Mar 20, 6:30AM CDT
Bacterin International Holdings, Inc. (NYSE MKT: BONE), a leader in the development of revolutionary bone graft materials and bioactive coatings for medical applications, announces that results utilizing OsteoSponge(R) bone graft for foot and ankle arthrodeses procedures has been published in the peer-reviewed journal Orthopedics. This is the second publication for Bacterin that highlights clinical outcomes of OsteoSponge(R) for foot and ankle fusion procedures.

Bacterin International Holdings posts higher net loss of USD12.7m in 2013
M2 - Thu Mar 20, 5:55AM CDT
Bone graft company Bacterin International Holdings (NYSE MKT:BONE) on Wednesday reported a net loss of USD12.7m (USD0.27 per common share) for the full year ended 31 December 2013.

Bacterin Announces Full Year 2013 Results
Business Wire - Wed Mar 19, 3:00PM CDT
Bacterin International Holdings, Inc. (NYSE MKT: BONE), a leader in the development of revolutionary bone graft material and coatings for medical applications, today reported financial results for the fourth quarter and full year ended December 31, 2013. The Company reported annual revenues of approximately $33.1 million and a net loss for the year of approximately $12.7 million, or ($.27) per common share.

Bacterin Announces the Launch of OsteoSTX, a Novel Biologic Product
Business Wire - Thu Mar 13, 6:30AM CDT
Bacterin International Holdings, Inc. (NYSE MKT: BONE) is pleased to announce the launch of OsteoSTX, a new novel allograft for orthopedic procedures. Utilizing Bacterin's proprietary demineralization technology, OsteoSTX are flexible cortical DBM matchsticks designed for multli-level and deformity spinal applications.

Bacterin Secures Additional OrbiMed Financing
Business Wire - Mon Mar 10, 6:30AM CDT
Bacterin International Holdings, Inc. (NYSE MKT: BONE), a leader in the development of revolutionary bone graft material and coatings for medical applications, announced the closing of an additional $4 million financing from OrbiMed.

Bacterin Updates Presentation Time at the Canaccord Genuity Musculoskeletal Conference
Business Wire - Wed Mar 05, 4:49PM CST
Bacterin International Holdings, Inc. (NYSE MKT: BONE), a leader in the development of revolutionary bone grafts and coatings for medical applications, today announced that its CEO, Dan Goldberger, will present at the Canaccord Genuity Musculoskeletal Conference, to be held March 11, 2014 at the Sheraton New Orleans. Bacterin's presentation will now take place Tuesday, March 11, 2014 at 2:50 PM CST.

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Guaranteed Income Policies Gain Traction Across States

Big Wins for Guaranteed Income Programs Boy, isn't it fascinating watching the political gears turn to embrace concepts like guaranteed income? This wave of enthusiasm isn't just words and ideas; it's now showing up in election results and ballot measures in multiple states. From California to Pennsylvania, voters appear to dig the idea of direct cash assistance to those...

Belay Diagnostics Clinches Second Palantir Title

Innovation in Liquid Biopsy Lands Belay Another Win Another round of applause is due for Belay Diagnostics, the brainy bunch in molecular diagnostics focused on CSF liquid biopsy for CNS cancers. This Chicago-based powerhouse clinched its second consecutive victory at the Palantir Foundry Buildcamp competition. The team must be on some winning streak, as they're not just...

Yealink's Bold AI Vision for the Workplace Unveiled

Yealink Sets the Stage for AI Conversations in Munich Ah, the buzz of innovation fills the air once again, as Yealink brings a dizzying array of tech bigwigs together at the Workplace Forward Summit in Munich. This ain't your regular business shindig—this is where the gears of the AI-powered future get some heavy oiling. Imagine 400 industry stalwarts, tech gurus,...

Starting Pet End-of-Life Talks: Why Timing Matters

Early Conversations Can Change Everything The minute you bring it up, let's be honest, nobody likes to talk about end-of-life decisions, not even for their pets. Yet, when you think about it, biding your time until things get critical isn't doing anyone any favors, especially not the furry ones. Drs. Brandon and Paola Beebout, two piercing minds from Kearney, Nebraska,...

Construction Partners' Georgia Move Bolsters Growth

CPI's Strategic Expansion into Georgia Here's an acquisition to keep your eye on: Construction Partners, Inc. (NASDAQ: ROAD), also known in the corridors of trading as CPI, is making a move that many of us in the business have been anticipating for some time. They’ve wrapped up the acquisition of Piedmont Paving, Inc., a Newnan, Georgia-based company. Now, for most...

Energy Fuels' Bold Moves: An Investor's Analysis

Energy Fuels Sets the Stage An era of rare earths and uranium dominance—this is the gauntlet Energy Fuels seems to be throwing down. With the acquisition of ASM and a Korean Metals Plant under its belt, they're flexing a strategy designed to boost the west's autonomous rare earth supply chain. That ain't a small feat, and it looks like they're gearing up for a battle...

China's Health-Driven Poverty Approach Offers Global Lessons

China's Health Strategy in Poverty Reduction Here's a story that's got global implications tucked into its every corner: China, a country that's been trying to mesh healthcare with poverty reduction, has caught the eye of international observers. This insight was splashed across the latest Lancet Commission report, showcased at Tsinghua University on October 29. It seems...

Dissecting the USDOT's New DBE/ACDBE Final Rule

The Landscape Shift in DBE/ACDBE Compliance When the USDOT decided to roll out their Final Rule in September, they didn't just shuffle the deck - they reshuffled the whole game for the Disadvantaged Business Enterprise (DBE) and Airport Concession Disadvantaged Business Enterprise (ACDBE) programs. Public agencies and businesses from coast to coast have been left...

GAC Hits Record with 223,000 Units Exported in 2026

GAC Gaining Ground Globally in 2026 China's GAC is making waves with its recent export figures. They've blitzed past the competition, exporting 223,000 units from January to October 2026. That's not just a number, it’s a record, with October alone seeing a hefty 26,017 units shipped—marking an impressive 80.8% growth compared to last year. A Strategic Push in Europe...

West Virginia Water's $850K Upgrade: A Local Boost

$850,000 For Aging Pipes: A Long-Needed Move Picture a dusty road in West Virginia—Old Route 38. Now, imagine it bustling with work crews hustling to give the town’s water infrastructure a much-needed facelift. West Virginia American Water is laying down $850,000 to replace 3,500 feet of worn-out pipe with durable PVC, aiming to curb service outages and ensure...